Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Actylis | Contract Pharma

What are you searching for?

Sign in

Search by

Actylis

Company Headquarters

4 Tri Harbor Court, , Port Washington, NY, 11050, US

Driving Directions Phone: View Phone
View website

Request more information from Actylis

Request more information from Actylis

Categories from Actylis

Chemicals and Raw Materials
Custom Manufacturing
Custom Media Development
Custom Sourcing
Excipients
Manufacturing, API
Manufacturing, Biologics
Manufacturing, Custom
Manufacturing, Nutraceuticals
Process Development/Scale-Up Services
Process R&D
R&D Services
Supplier, Excipients
Supplier, Fine Chemicals
Supplier, Raw Materials
Eliminating Complexity for Pharma Teams

VideoBites

Eliminating Complexity for Pharma Teams

Jai Murthy of Actylis shares insight on overcoming supply chain fragility, buffer prep solutions, and approaches to customization.

Released By Actylis

Related Content

Collaborations & Alliances

ExploRNA, Łukasiewicz Research Network Partner on GMP Manufacturing of Next-Gen mRNA Cap Analogs

Łukasiewicz, known for advanced chemical synthesis and production scaling capabilities, will help ExploRNA ramp up its mRNA manufacturing.

By: Patrick Lavery

Breaking News

WuXi XDC Secures GMP Release for Singapore Manufacturing Site

The designation applies to the site’s BCM3 antibody intermediate and conjugated drug substance dual-function production line, and DP4 facility.

By: Patrick Lavery

Breaking News

Made Scientific Acquires Cell Therapy Facility From National Resilience

The 85,000-sq.-ft. East Norriton site adds GMP cleanrooms, fill-finish capacity, and immediate onboarding for cell therapy sponsors.

By: Charlie Sternberg

Breaking News

Upperton Gains MHRA Approval for Nottingham Sterile Manufacturing Site

License variation supports early-phase GMP manufacture at Nottingham facility.

By: Charlie Sternberg

Northway Biotech Opens €61M Cell Therapy CDMO Facility in Vilnius

The 3,500-square-meter BIO CITY III facility adds up to 20 cGMP manufacturing lines for cell therapies and personalized medicine.

By: Tim Wright

Breaking News

PerkinElmer Completes SimoTech Acquisition

Deal expands PerkinElmer’s automation, GMP IT and digital manufacturing capabilities for life sciences customers.

By: Charlie Sternberg

Breaking News

Q-VANT Santiago Facility Earns EXCiPACT GMP Certification

Certification supports commercial-scale production of QS-21 and other high-purity saponin fractions for human and veterinary vaccines.

By: Charlie Sternberg

Breaking News

Evonik Invests $108M in Vancouver GMP Facility

New site will expand lipid-based drug delivery manufacturing capacity.

By: Charlie Sternberg

Collaborations & Alliances

Genezen to Offer Access to 4basebio Synthetic DNA Platform for Viral Vectors

Drug developers will be able to use 4basebio’s research use only, high-quality, GMP-grade development and clinical programs.

By: Patrick Lavery

Breaking News

Körber Releases PAS-X MES 3.4.2 for Pharma Manufacturing

The latest version of Körber’s PAS-X Manufacturing Execution System adds expanded shopfloor capabilities, deployment automation, infrastructure efficiency improvements and more.

By: Charlie Sternberg

Breaking News

Landmark Bio, Syngoi Now to Operate Under Artis BioSolutions Name

This brings Artis’ U.S.-based development and GMP manufacturing and Spain-based enzymatic synthetic DNA operations under one name.

By: Patrick Lavery

Sponsored Content

The Art and Science of Getting Tech Transfer Right First Time

Why successful technology transfer depends on early planning, process understanding and close collaboration from development through GMP manufacturing.

Released By Upperton

Breaking News

Pace Life Sciences Completes FDA Inspection at Small Molecule Center of Excellence

The Research Triangle Park facility supports GMP analytical testing across drug development and manufacturing.

By: Charlie Sternberg

Collaborations & Alliances

Forge Biologics Launches AAV Development, cGMP Manufacturing Partnership with Restore Vision

The collaboration supports Restore Vision’s investigational therapy for patients with retinitis pigmentosa.

By: Patrick Lavery

Collaborations & Alliances

OXB Signs AAV Manufacturing Deal with Plowshare Therapies

Agreement covers process development and GMP manufacturing for Plowshare’s AAV-based rare disease program.

By: Charlie Sternberg